Rubella Antibody IgM Test

If you are pregnant or planning to become pregnant, a recent rubella infection can cause devastating harm to a developing baby, including heart defects, blindness, deafness, and intellectual disability. Rubella IgM (immunoglobulin M, the first antibody your immune system makes when it encounters rubella) is the test that answers one specific question: have you been infected with rubella recently?

This is not the same as checking whether you are immune. Immunity is assessed with a different test, rubella IgG (immunoglobulin G), which measures the long lasting antibodies that remain after infection or vaccination. Rubella IgM appears within about 3 to 10 days of infection, peaks during the first weeks, and usually fades within about two months. Its presence is a signal of active or very recent infection, not of lasting protection.

What Rubella IgM Actually Tells You

Rubella IgM is made by B cells, a type of white blood cell that produces antibodies. When your body first meets the rubella virus, B cells start churning out IgM within days. IgM is the immune system's rapid first responder. It circulates in the blood for a few weeks, then production shifts to IgG, a smaller, more targeted antibody that stays in your blood for years or even a lifetime.

Because IgM is short lived, its presence in a blood sample points to a recent encounter with the virus. A positive result paired with symptoms like rash, fever, or joint pain strongly suggests active rubella. In a newborn, a positive rubella IgM indicates the baby was infected before birth, since IgM molecules are too large to cross the placenta from mother to child.

Interpreting Your Results

Rubella IgM results are reported as positive, negative, or equivocal. Unlike a cholesterol number that falls on a spectrum, this is closer to a yes or no answer. The interpretation depends heavily on your clinical context and on what your rubella IgG result shows at the same time.

Rubella Infection and Pregnancy

The reason rubella IgM matters most is pregnancy. When a woman contracts rubella during the first trimester, the risk of congenital rubella syndrome (CRS) is very high. CRS can cause congenital heart defects, cataracts, hearing loss, and developmental delays. In a study of pregnant women in Tanzania with acute rubella infection (confirmed by positive IgM), 83.6% had adverse pregnancy outcomes, and about 1 in 100 pregnancies resulted in congenital rubella syndrome. The risk was highest when IgM was positive during the first trimester.

A systematic review of rubella infection during pregnancy found that early pregnancy infections markedly increase the risk of miscarriage, fetal death, infant death, and congenital rubella syndrome. This is why detecting recent infection matters so much in pregnant women, even though rubella itself is typically a mild illness in adults.

When Results Can Be Misleading

The single biggest problem with rubella IgM testing is false positives, especially in countries where rubella has been nearly eliminated through vaccination. In these settings, rubella is so rare that a positive IgM result is far more likely to be wrong than right.

• In France, among over 4,000 pregnant women referred for positive IgM or possible rubella exposure, only 1.4% of positive IgM results reflected a true primary infection.
• In Ontario, Canada, only about 3.6% of positive rubella IgM results turned out to be true infections, meaning more than 96 out of 100 positive results were false alarms.
• In Belgium in 2017, no confirmed rubella cases were found despite 748 positive and 394 equivocal IgM results across the country.

Cross-reactivity, where your immune system's response to one infection accidentally triggers a positive result on a test for a different infection, is a major driver of false positives. Other infections, including parvovirus B19, measles, dengue, and roseola, can trigger a positive rubella IgM. Rheumatoid factor (an autoimmune protein found in conditions like rheumatoid arthritis) is another known cause: in one study, 24 out of 44 samples containing rheumatoid factor tested falsely positive for rubella IgM.

Test kit variation adds another layer of uncertainty. A head-to-head evaluation of eight commercial rubella IgM test kits found that their ability to correctly detect true infections ranged from 63% to 100%, while their ability to correctly rule out uninfected people ranged from 80% to 99.5%. No single kit scored above 90% on both measures. A separate analysis that combined results from 15 rubella IgM test kits found that, on average, they correctly detected about 97% of true infections and correctly ruled out about 96% of non-infections, but individual kits varied widely.